Bac0n wrote: ok enough FUD, as usual old uncle Bac0n has to tell the mouth breathers how this actually works.
so first off here are the nasdaq listing requirements:
source:
Nasdaq Initial Listing Guide Listing Timeline While it generally takes four to six weeks to process a listing application, this time frame is variable and may be shortened considerably, if the application raises no issues and the company responds quickly to Staff comments.
Week 1. Company submits application for listing and Nasdaq Listing Qualifications Staff begins its review.
Weeks 2-3. Staff completes its preliminary review and prepares comment letter.
Weeks 3-4. Company addresses any issues raised by Staff.
Weeks 5-6. Staff completes their review and company is approved for listing ok so out of those requirements, where is HIVE?
week 1. company has submitted its application, in the case of a canadian company the 40F form. so HIVE is at the very beginning of this process.
where is BITF?
all the above steps have been completed, BITF has already received approval for listing.
so to summarize because I know many of you suffer from learning disabilites.
BITF has completed the above process and received approval.
HIVE is still on the 1st step.
im not sure what AlphaJ is smoking by "riding the NASDAQ bump", at this stage there is no indication what so ever that HIVE is going to get approved for NASDAQ listing. all that has happened so far, is they have applied. the end.
They still havent had a third party audit which is usually a requirement for weeks 2 - 4 during the NASDAQ staff review.
so no HIVE is not approved for NASDAQ, HIVE is not guaranteed a NASDAQ listing, I would even go as far to say that its unlikely HIVE gets a NASDAQ in the short term. and by short term I mean by end of 2021.
hope this clears things up for the children
*puffs cigar*
-Bac0n